Fresenius Medical Care is a global healthcare group that specializes in providing products and services for dialysis, hospitals, and patient care. As the world's leading provider of renal therapies for patients with chronic kidney failure, Fresenius has been setting standards in renal therapies for over 25 years. They manufacture a full range of dialysis products and operate over 4,100 centers in more than 50 countries, serving over 345,000 patients worldwide.

Their provider business, NephroCare, operates in over 40 countries across Europe, the Middle East, Africa, and Latin America. With over 1,000 dialysis centers and a dedicated team of more than 31,000 staff, NephroCare provides high-quality care and performs about 16 million treatments each year for over 100,000 patients. Fresenius Medical Care is committed to improving patients' lives by delivering state-of-the-art renal dialysis, creating a better future, and offering tailor-made therapy options.

They prioritize sustainability, innovation, and affordability, and aim to support healthcare systems with their innovative care concepts. Stay informed with their latest COVID-19 updates and news about their CKD care, dialysis care, and other care options on their website